Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Bonis

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Anales Otorrinolaringologicos Ibero-Americanos|June 3, 2005
[Malignant external otitis. A pattern to bear always in mind]F Arias Marzán, L Betancor Martínez, G de Lucas Carmona, et al.
Anales Otorrinolaringologicos Ibero-Americanos|August 17, 2006
[Rhabdomyosarcoma of soft palate. A case on purpose]F Arias Marzán, M De Bonis Redondo, F Redondo Ventura, et al.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor responseC Marchetti, A Fagotti, R Fruscio, et al.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
ESMO Open|April 2, 2025
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Anales Otorrinolaringologicos Ibero-Americanos|June 3, 2005
[Malignant external otitis. A pattern to bear always in mind]F Arias Marzán, L Betancor Martínez, G de Lucas Carmona, et al.
Anales Otorrinolaringologicos Ibero-Americanos|August 17, 2006
[Rhabdomyosarcoma of soft palate. A case on purpose]F Arias Marzán, M De Bonis Redondo, F Redondo Ventura, et al.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor responseC Marchetti, A Fagotti, R Fruscio, et al.
ESMO Open|May 30, 2025
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
ESMO Open|April 2, 2025
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studyC Marchetti, A Fagotti, R Fruscio, et al.
Pageof 6